Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

XEN-45 Gel Stent Versus Trabeculectomy in Glaucoma: Gold-Standard Pathway Study (GPS)

NCT03654885 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT03654885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03654885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
XEN-45 Gel Stent Versus Trabeculectomy in Glaucoma: Gold-Standard Pathway Study (GPS)
Lead sponsor
Allergan
Phase
Phase 4
Overall status
Completed
Start date
October 1, 2018
Completion date
May 13, 2021
Enrollment
158 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma